Wikipedia Encyclopedia

DTaP-IPV vaccine

DTaP-IPV vaccine

DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1][2]

DTaP-IPV vaccine
DPT-IPV vaccine in Japan
Combination of
DTaP vaccineVaccine
Inactivated poliovirus vaccineVaccine
Clinical data
Trade namesKinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others
Other namesdiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
AHFS/Drugs.comKinrix Quadracel
  • AU: A
Routes of
Intramuscular injection
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
CAS Number

It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.[1]

Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[3] and Quadracel from Sanofi Pasteur.[4]

Repevax is available in the UK.[5][6]

Within Japan, the formulation is called 四種混合(shishukongou - "mixture of 4"). Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic')[7].[8] A previous product by Takeda Pharmaceutical Company has been withdrawn by the company.[9]


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.